Home/Search
2021 SCAI SHOCK
2021 SCAI SHOCK: Alphabetical Content Listing
Best SHOCK Oral Abstracts
Management and outcomes of myocarditis with cardiogenic shock due to multisystem inflammatory syndrome in adults following COVID-19 – a single center experience
Dr. Retesh Bajaj, MBBS BSc PhD
Peripheral Blood Neutrophil-to-Lymphocyte Ratio is Associated with Mortality across the Spectrum of Cardiogenic Shock Severity
Yishay Szekely, MD
Survival advantage of an intra-aortic balloon pump, YES, NO or an unsolved riddle
Mahesh Kumar Batra, M.B.B.S.
Welcoming Remarks
CSRC Cardiogenic Shock Think Thank 2021 Update
CSRC and AHA Shock Initiative
David A. Morrow, MD, MPH
FDA Priorities for Shock 2021-2022
Nicole Gillette
Informed Consent for Shock Research
Nick E.J. West, MD
International Research Networks
Alastair Proudfoot, MBBS, PhD
Overview of CSRC Cardiogenic Shock Think Tank
Mitchell W. Krucoff, M.D., FSCAI
Panel Discussion
Shock Academic Research Consortium Update
Ron Waksman, M.D.
Contemporary Data and Science: Part 1
Cardiogenic Shock Working Group Update
Navin K. Kapur, M.D., FSCAI
DanGer Shock Trial
Jacob Moller, M.D.
HERACLES Trial
Divaka Perera, M.D.
Japanese-PVAD Registry
Junya Ako, MD, PhD
National Cardiogenic Shock Initiative
William W. O'Neill, MD, MSCAI
Welcoming Remarks
William W. O'Neill, MD, MSCAI
Contemporary Data and Science: Part 2
American Heart Initiative on Cardiogenic Shock
Mariell Jessup, M.D.
“Real-World” Registries
Alexander G. Truesdell, M.D., FSCAI
RECOVER III: Women and Shock
Alexandra J. Lansky, M.D., MSCAI
RECOVER IV Trial
Gregg W. Stone, M.D.
Super-saturated Oxygen After Support
Babar B Basir, DO, FSCAI
Welcoming Remarks
Roxana Mehran, M.D., MSCAI
Contemporary Data and Science: Part 3
ANCHOR
Gilles Montalescot, MD, PhD
CABG-SHOCK
Andreas Boening, M.D.
ECLS-SHOCK
Holger Thiele, MD
EUROSHOCK
Marcus Flather, M.D.
Welcoming Remarks
Holger Thiele, MD
Disparities in Care and Advocacy Initiatives
Advocacy and Legislation
J. Jeffrey Marshall, M.D., MSCAI
Disparities Across the US
Alejandro Lemor, M.D., FSCAI
Underrepresented Minorities and Shock
Nasrien E. Ibrahim, MD
Welcoming Remarks
Wayne B. Batchelor, M.D., FSCAI
Women and Shock
Sara Cecilia Martinez, M.D., Ph.D., FSCAI
ECMO for the Cardiologist
Case Conclusion, Part 2
Pedro A Villablanca, M.D., FSCAI
Case Presentation, Part 1
Pedro A Villablanca, M.D., FSCAI
ECMO vs. ECPR: What’s the Difference?
Timothy D. Smith, M.D., FSCAI
Panel Discussion
Program Building: How to Get Started
Allison G. Dupont, M.D., FSCAI
Selection, Selection, Selection…Who to Place on ECMO?
Erik C. Osborn, MD
Weaning and Exit Strategies
Stacey H. Brann, MD
MCS in Treating Left, Right, and Bi-Ventricular Shock
Bi-Ventricular MCS With LA-AO and RA-PA Pumps: How It Works, Case Selection, Pros and Cons
Amir Kaki, M.D., FSCAI
How and When to Escalate MCS
Daniel Burkhoff, M.D., PhD
Left-Sided MCS With LA-AO Pump: How It Works, Case Selection, Pros and Cons
Khaldoon Alaswad, M.D., FSCAI
Right-Sided MCS With RA-PA Pump: How It Works, Case Selection, Pros and Cons
Timothy D. Smith, M.D., FSCAI
V-A ECMO: How It Works, Case Selection, Pros and Cons
Elsayed Abo-Salem, M.D.
Multidisciplinary Team-Based Approach to Cardiogenic Shock
The National CSI Approach
Babar B Basir, DO, FSCAI
Optimizing Antiplatelet Therapy in Cardiogenic Shock
Anti-platelet Concerns and Pharmacodynamics in Cardiogenic Shock
George D. Dangas, M.D., Ph.D., MSCAI
Cangrelor: Trial Data, Indications, and Contraindications
Deepak L. Bhatt, M.D., M.P.H., MSCAI
Case Presentation With Questions
Suzanne J. Baron, M.D., FSCAI
Case Presentation
Suzanne J. Baron, M.D., FSCAI
Optimal “Recipe” for Antiplatelet Management in Shock: Present and Future
Jolanta Maria Siller-Matula, MD, PhD
Practical Interpretation of Shock Hemodynamics
Case 1 Conclusion
Pooja M. Swamy, MD, FSCAI
Case 1 Presentation
Pooja M. Swamy, MD, FSCAI
Case 2 Conclusion
Lorenzo Azzalini, MD, PhD, MSc, FSCAI
Case 2 Presentation
Lorenzo Azzalini, MD, PhD, MSc, FSCAI
Case 3 Conclusion
Jacob Abraham, MD
Case 3 Presentation
Jacob Abraham, MD
SCAI SHOCK Abstracts
Percutaneous edge-to-edge treatment of an acute mitral regurgitation in a patient with late-presenting STEMI complicated by cardiogenic shock
Saverio Continisio, M.D.
Urgent Use of Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from the Progress-CTO Registry
Judit Karacsonyi, MD, PhD
SCAI SHOCK Case Presentations
Axillary IABP Prolapse into the Ascending Aorta: A Rare Anatomic Challenge
Harsh Doshi, M.D.
Cardiogenic Shock in COVID-19 and Hostile Vascular Access
Saraschandra Vallabhajosyula, MD MSc, FSCAI
ECMO ASSISTED PRIMARY PCI in OHCA and CARDIOGENIC SHOCK (STEMI AMICS)
Vishnu A Ashok, M.B.B.S, MD (Internal Medicine), DNB(Cardiology)
ECMO supported PROTECTED CHIP PCI in Post CABG ACS AMICS and in hospital Cardiac arrest
Sivaramakrishnan Manoj, MBBS, MD, DNB, DM, DNB, FACC, FESC, FSCAI
Ischemic Cardiogenic Shock and Temporary Mechanical Circulatory Support Bridge to Decision
Rosario della Cella Figueredo, M.D.
Collapse: Right Coronary Artery Chronic Total Occlusion Percutaneous Coronary Intervention with a Serious Complication
Judit Karacsonyi, MD, PhD
Incessant Ventricular Tachycardia and Cardiogenic Shock: VA-ECMO as Bridge to Recovery
Auras R. Atreya, MD, MPH, FACC, FHRS
Late presenting acute myocardial infarction with evolving cardiogenic shock
James Xu, MBBS, FRACP
Left Ventricular Outflow Obstruction From Mechanical Circulatory Support in Critical Aortic Stenosis: A Cautionary Tale
Vinoy Singh Prasad, M.D., FSCAI
MCS PROTECTED CHIP PCI in ACS – AMICS with recurrent In Hospital Cardiac Arrest
Sivaramakrishnan Manoj, MBBS, MD, DNB, DM, DNB, FACC, FESC, FSCAI
Out-of-hospital cardiac arrest with anterior STEMI
Saraschandra Vallabhajosyula, MD MSc, FSCAI
Pheochromocytoma Induced Cardiogenic Shock
Mohammad Hassan Pervaiz, M.D., FSCAI
severe fulminant biventricular failure resulting in cardiogenic shock, dramatically responded to medical therapy with full recovery of systolic function.
Mohanad Shehadeh, M.D.
The importance of right heart catheterization in-patient with acute myocardial infarction complicated by cardiogenic shock.
Shabib Abdullah Al Aasmi, M.D.
Triple coronary artery occlusion causing cardiogenic shock and cardiac arrest (early escalation of mechanical circulatory support makes difference)
Mohamed Salah Abdelghani, M.D.
Shock Critical Care
Escalation and Weaning in Refractory Shock
Albert James Hicks III, MD, MPH
Futility: When is Enough Enough?
Shashank Sinha, MD, MSc
Right Ventricular Shock: Support and Lysis
Behnam N. Tehrani, M.D.
Shock Critical Care
Susanna Price, MBBS
Welcoming Remarks
Angela Taylor, M.D.
Shock Diagnosis and Treatment
Inotropes and Pressors
Robert O. Roswell, MD
Mastery of Advanced Hemodynamics
Daniel Burkhoff, M.D., PhD
MCS: Who, What, When, How?
Babar B Basir, DO, FSCAI
Program Chair Welcome
William W. O'Neill, MD, MSCAI
Revised SCAI Shock Definitions 2021
Timothy D. Henry, M.D., MSCAI
Shock Protocols, Teams, Centers, and Networks
Shock Complicated by Cardiac Arrest
Demetri Yannopoulos, M.D., FSCAI
Shock Protocols
Alastair Proudfoot, MBBS, PhD
Shock Teams - Who are the Players?
Jason Neil Katz, MD
Spoke-and-Hub Networks and Transfers
Carolyn M. Rosner, MSN, RN, FNP-BC
Welcoming Remarks
Alexander G. Truesdell, M.D., FSCAI
Super-Saturated Oxygen Therapy in AMI and Cardiogenic Shock
AMI Case Example & Discussion
Steven J. Yakubov, M.D., MSCAI
AMI #2 Case Example & Discussion
James Spears, MD
Introduction to SSO2
Richard Schatz, M.D.
Panel Discussion
SSO2 in Cardiogenic Shock
Babar B Basir, DO, FSCAI
The Science of Infarct Reduction and Improving Microvascular Flow With SSO2
Gregg W. Stone, M.D.
The Dark Side of The Moon: Non-Ischemic Shock
Case Presentation
Abhishek Jaiswal, M.B.B.S.
IABP in Non-ischemic Shock
Corstiaan den Uil, MD, PhD
Impella in Non-ischemic Shock
Babar B Basir, DO, FSCAI
Non-Ischemic Shock: Pathophysiology and Recent Insights
Susanna Price, MBBS
Panel Discussion
V A ECMO: One Size Fits All
Shelley Hall, M.D.
Top-Shock: Case Presentations
Acute Papillary Muscle rupture in STEMI complicated by Cardiogenic shock during the Covid-19 era
Mohit Pahuja, MD
Left Atrial Veno-Arterial (LAVA) ECMO for Cardiogenic Shock and Acute Aortic Regurgitation as a Bridge to Valve-in-Valve TAVR and PCI
Pedro A Engel Gonzalez, M.D., FSCAI
The “Double-Barrel” Impella CP (DBCP): A Novel Option in the Mechanical Circulatory Support Toolbox
Alec Vishnevsky, M.D.
Welcoming Remarks
World View on Cardiogenic Shock Management: Part 1
Canadian Perspective
Derek So, M.D.
German Perspective
Alexander Ghanem, MD, PhD
Italian Perspective
Giuseppe Tarantini, MD, PhD
Latin American Perspective
Libardo Augusto, M.D.
Welcoming Remarks
Mirvat Alasnag, M.D., FSCAI
World View on Cardiogenic Shock Management: Part 2
Australia-New Zealand Perspective
Gemma Figtree, MD
Indian Perspective
Suresh Rao K G, M.D.
Japanese Perspective
Makiko Nakamura, MD, PhD
Saudi Arabia Perspective
Khaled Al-Shaibi, M.D.
Welcoming Remarks
Ashok Seth, FRCP,, MSCAI